C - Chemistry – Metallurgy – 07 – J
Patent
C - Chemistry, Metallurgy
07
J
C07J 1/00 (2006.01) A61K 31/565 (2006.01) A61P 5/30 (2006.01)
Patent
CA 2692727
The invention refers to 80-substituted estra-1,3,5(10)-triene derivatives of general formula (I), their use as pharmaceutical active ingredients, which have in vitro a higher affinity to estrogen receptor preparations from rat prostates than to estrogen receptor preparations from rat uteri and in vivo a preferential action in the ovary in comparison to the uterus, their production, their therapeutic use and pharmaceutical dispensing forms that contain the new compounds.
La présente invention concerne des dérivés estra-1,3,5(10)-triènes à substitution 8ß de formule générale (I) ; leur utilisation en tant que principes actifs pharmaceutiques, qui présentent, in vitro, vis-à-vis de préparations de récepteurs d'strogènes de la prostate de rats, une affinité supérieure à celle relative aux préparations de récepteurs d'strogènes de l'utérus de rats, et ayant de préférence, in vivo, une action plus marquée sur les ovaires que sur l'utérus ; leur production ; leur utilisation aux fins thérapeutiques et leur formes pharmaceutiques, destinées à être administrées, renfermant ces nouveaux composés.
Braeuer Nico
Fritzemeier Karl-Heinrich
Muhn Hans-Peter
Peters Olaf
Prelle Katja
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
8-beta-substituted estratrienes as selectively active estrogens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-beta-substituted estratrienes as selectively active estrogens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-beta-substituted estratrienes as selectively active estrogens will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1902888